Clinical Trials
2 trialsNCT03914300 2026-06-01
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00001160 2026-05-12
Studies on Tumors of the Thyroid
National Institutes of Health Clinical Center (CC)
Recruiting